Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

8.3%

1 terminated out of 12 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

80% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
P 4 (1)

Trial Status

Completed4
Unknown3
Recruiting2
Active Not Recruiting1
Terminated1
Withdrawn1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (12)

Research Network

Activity Timeline